Taken together, ERBB4 signaling adjacent to the T2DM and renal cell carcinogenetic mechanism subnetworks can be studied as potential promising targets and biomarkers for T2DM-associated renal cell carcinoma. The gene discussed is ERBB4; the disease is type 2 diabetes mellitus.